230 related articles for article (PubMed ID: 10356577)
21. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
Wolbach J; Capoccia K
Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297
[No Abstract] [Full Text] [Related]
22. The medical merry-go-round: drugs for 1998 are new but not novel.
Gilden D
GMHC Treat Issues; 1997-1998 Winter; 12(1):18-25. PubMed ID: 11364984
[TBL] [Abstract][Full Text] [Related]
23. I want a new drug. An overview of three new anti-HIV drugs.
Simmons P
Res Initiat Treat Action; 1998 Jun; 4(3):9-11. PubMed ID: 11365539
[TBL] [Abstract][Full Text] [Related]
24. Preliminary report on 1592.
AIDS Clin Care; 1997 Sep; 9(9):71. PubMed ID: 11364756
[TBL] [Abstract][Full Text] [Related]
25. HIV's potent cocktail.
Lusky K
Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
[No Abstract] [Full Text] [Related]
26. [Valuable combination partner. Great benefit for therapy naive patients].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():82-4. PubMed ID: 15373061
[No Abstract] [Full Text] [Related]
27. Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.
Follansbee S; Deeks S; Bartnoff H
Newsline People AIDS Coalit N Y; 1998 Mar; ():7-14. PubMed ID: 11367453
[TBL] [Abstract][Full Text] [Related]
28. Selected highlights from the 5th Conference on Retroviruses and Opportunistic Infections.
Bartnof HS
BETA; 1998 Apr; ():49-56. PubMed ID: 11365269
[TBL] [Abstract][Full Text] [Related]
29. Three new drugs for HIV infection.
Med Lett Drugs Ther; 1998 Dec; 40(1041):114-6. PubMed ID: 9854567
[No Abstract] [Full Text] [Related]
30. A new approach to initial antiretroviral therapy: protease-sparing combination regimens.
Hanna L
BETA; 1998 Oct; ():9-13. PubMed ID: 11365999
[TBL] [Abstract][Full Text] [Related]
31. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
Martínez E; Arnaiz JA; Podzamczer D; Dalmau D; Ribera E; Domingo P; Knobel H; Riera M; Pedrol E; Force L; Llibre JM; Segura F; Richart C; Cortés C; Javaloyas M; Aranda M; Cruceta A; de Lazzari E; Gatell JM;
N Engl J Med; 2003 Sep; 349(11):1036-46. PubMed ID: 12968087
[TBL] [Abstract][Full Text] [Related]
32. The year in review: antiretroviral treatment.
Hirschel B; Opravil M
AIDS; 1999; 13 Suppl A():S177-87. PubMed ID: 10885775
[No Abstract] [Full Text] [Related]
33. [The 39th ICAAC (San Francisco) and the 7th European Conference on Clinical Aspects and Treatment of HIV-infection (Lisbon). HIV infection: antiretroviral agents in the development and trial stage].
Duval X
Presse Med; 2000 Feb; 29(5):253-6. PubMed ID: 10701407
[No Abstract] [Full Text] [Related]
34. Update on antivirals.
Proj Inf Perspect; 1997 Nov; (23):8-11. PubMed ID: 11365381
[TBL] [Abstract][Full Text] [Related]
35. Salvage therapy studies.
Proj Inf Perspect; 1998 Sep; (25):7. PubMed ID: 11365850
[TBL] [Abstract][Full Text] [Related]
36. Some competition for 1592.
GMHC Treat Issues; 1997; 11(4/5):10-1. PubMed ID: 11364373
[TBL] [Abstract][Full Text] [Related]
37. New drugs in development.
Proj Inf Perspect; 1998 Sep; (25):8. PubMed ID: 11365851
[TBL] [Abstract][Full Text] [Related]
38. Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes.
Chiesa E; Bini T; Adorni F; Capetti A; Rizzardini G; Faggion I; Mussini C; Sollima S; Melzi S; Bongiovanni M; Tordato F; Cicconi P; Castelnuovo B; Rusconi S; d'Arminio Monforte A
Antivir Ther; 2003 Feb; 8(1):27-35. PubMed ID: 12713061
[TBL] [Abstract][Full Text] [Related]
39. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial.
Molina JM; Journot V; Morand-Joubert L; Yéni P; Rozenbaum W; Rancinan C; Fournier S; Morlat P; Palmer P; Dupont B; Goujard C; Dellamonica P; Collin F; Poizot-Martin I; Chene G;
J Infect Dis; 2005 Mar; 191(6):830-9. PubMed ID: 15717256
[TBL] [Abstract][Full Text] [Related]
40. Another take on when to start and how to succeed.
Friedland GH
AIDS Clin Care; 2001 Sep; 13(9):82. PubMed ID: 11547600
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
